CB Financial Services (NASDAQ:CBFV) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.44 by 18.18 percent. This is unchanged from the same period last year.
Wells Fargo Maintains Overweight on Biogen, Raises Price Target to $350
Wells Fargo analyst Mohit Bansal maintains Biogen (NASDAQ:BIIB) with a Overweight and raises the price target from $265 to $350.